MDCX MEDICUS PHARMA LTD
FollowCommon Shares, no par value (common), issuer CIK 1997296
Filings received so far for Q3 2026: 1 13F filer report a position in MDCX shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.
- Melani Kenneth R. (group Melani Kenneth R.)
3,248,741 shares, 3.6% in a 13G/A as of 2026-09-30,0000950142-26-002781
Accepted , ingested
Insider trades
| Owner | Date | Shares | Price | Filing |
|---|---|---|---|---|
| Smith Andrew Alasdairofficer (Chief Operating Officer) | 2026-11-13 | +14,534 A | $1.72 | Form 4 |
| Mehmud Faisalofficer (Chief Medical Officer) | 2026-11-13 | +14,534 A | $1.72 | Form 4 |
| May Sara R.director | 2026-11-13 | +5,813 A | $1.72 | Form 4 |
| MAHAFFY PATRICK Jdirector | 2026-11-13 | +14,534 A | $1.72 | Form 4 |
| Kaiser Larrydirector | 2026-11-13 | +14,534 A | $1.72 | Form 4 |
| Ciaruffoli Robert J.director | 2026-11-13 | +72,674 A | $1.72 | Form 4 |
| Brennan Edward J.officer (SVP, Medical Affairs) | 2026-11-13 | +14,534 A | $1.72 | Form 4 |
| Bonner Carolyn F.officer (President and CFO) | 2026-11-13 | +29,069 A | $1.72 | Form 4 |
| Bokhari Razadirector, officer (Chief Executive Officer), 10% owner | 2026-11-13 | +436,046 A | $1.72 | Form 4 |
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| STALEY CAPITAL ADVISERS INC | 10,000 | $1.61K | <0.01% | new | 13F-HRTimeline |
Events
Smith Andrew Alasdair acquired 14,534 MDCX shares on 2026-11-13, Form 4 filed 2026-11-17. 0000950142-26-003111
Accepted , ingestedMehmud Faisal acquired 14,534 MDCX shares on 2026-11-13, Form 4 filed 2026-11-17. 0000950142-26-003110
Accepted , ingestedMay Sara R. acquired 5,813 MDCX shares on 2026-11-13, Form 4 filed 2026-11-17. 0000950142-26-003109
Accepted , ingestedMAHAFFY PATRICK J acquired 14,534 MDCX shares on 2026-11-13, Form 4 filed 2026-11-17. 0000950142-26-003108
Accepted , ingestedKaiser Larry acquired 14,534 MDCX shares on 2026-11-13, Form 4 filed 2026-11-17. 0000950142-26-003107
Accepted , ingestedCiaruffoli Robert J. acquired 72,674 MDCX shares on 2026-11-13, Form 4 filed 2026-11-17. 0000950142-26-003106
Accepted , ingestedBrennan Edward J. acquired 14,534 MDCX shares on 2026-11-13, Form 4 filed 2026-11-17. 0000950142-26-003105
Accepted , ingestedBonner Carolyn F. acquired 29,069 MDCX shares on 2026-11-13, Form 4 filed 2026-11-17. 0000950142-26-003104
Accepted , ingestedBokhari Raza acquired 436,046 MDCX shares on 2026-11-13, Form 4 filed 2026-11-17. 0000950142-26-003103
Accepted , ingestedMelani Kenneth R. and 1 other reporting person reported 3,248,741 MDCX shares, 3.6% of the class, as of 2026-09-30, in a 13G/A filed 2026-10-16. 0000950142-26-002781
Accepted , ingested